Study Title
Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Study Details
Description:
A neuroendocrine tumor is a rare type of tumor. It comes from body cells called neuroendocrine cells. Sometimes, these tumors develop in the gastrointestinal tract and pancreas. Researchers want to find out if a combination of drugs can shrink these tumors.
Sponsor:
National Cancer Institute
Contacts:
Joy Zou, R.N.joy.zou@nih.gov
(240) 760-6153
Frank I Lin, M.D.frank.lin2@nih.gov
(240) 760-6166
Government Study Link:
NCT04086485 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468